231 related articles for article (PubMed ID: 31634300)
1. Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series.
Ordóñez-Rubiano EG; Solano-Noguera DF; Row W; Weinberg J; Tatsui CE; Johnson JM; Gule-Monroe MK
Spine (Phila Pa 1976); 2019 Nov; 44(21):E1248-E1255. PubMed ID: 31634300
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.
Sakushima K; Yabe I; Shiga T; Yashima-Yamada M; Tsuji-Akimoto S; Terae S; Sasaki H
J Neurol; 2011 Feb; 258(2):227-30. PubMed ID: 20820799
[TBL] [Abstract][Full Text] [Related]
3.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET/CT findings in a case of spinal cord sarcoidosis.
Suga K; Matsunaga N; Yasuhiko K; Matsunaga N; Seki N; Kataoka H; Taguchi T
Clin Nucl Med; 2011 May; 36(5):382-5. PubMed ID: 21467861
[No Abstract] [Full Text] [Related]
5. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
[TBL] [Abstract][Full Text] [Related]
6.
Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of quantitative assessment of cardiac
Lebasnier A; Legallois D; Bienvenu B; Bergot E; Desmonts C; Zalcman G; Agostini D; Manrique A
Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET successfully detects spinal cord sarcoidosis.
Ota K; Tsunemi T; Saito K; Yamanami F; Watanabe M; Irioka T; Mizusawa H
J Neurol; 2009 Nov; 256(11):1943-6. PubMed ID: 19685103
[TBL] [Abstract][Full Text] [Related]
10. Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports.
Clarençon F; Silbermann-Hoffman O; Lebreton C; Fernandez P; Kerrou K; Marchand-Adam S; Hourseau M; Schouman-Claeys E; Feydy A
Spine (Phila Pa 1976); 2007 Sep; 32(20):E594-7. PubMed ID: 17873802
[TBL] [Abstract][Full Text] [Related]
11. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
Braun JJ; Kessler R; Constantinesco A; Imperiale A
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
[TBL] [Abstract][Full Text] [Related]
13.
Gholamrezanezhad A; Mehta L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(3):172-174. PubMed ID: 28526323
[TBL] [Abstract][Full Text] [Related]
14. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations.
Akaike G; Itani M; Shah H; Ahuja J; Yilmaz Gunes B; Assaker R; Behnia F
Radiographics; 2018; 38(5):1536-1549. PubMed ID: 30118393
[TBL] [Abstract][Full Text] [Related]
15. The Utility of
Chen H; Jin R; Wang Y; Li L; Li K; He Y
Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
17. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
[TBL] [Abstract][Full Text] [Related]
18. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of
Rubini G; Ferrari C; Altini C; Cimino A; Fanelli M; Niccoli Asabella A
Curr Med Imaging Rev; 2019; 15(1):32-38. PubMed ID: 31964325
[TBL] [Abstract][Full Text] [Related]
20. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
Tang R; Wang JT; Wang L; Le K; Huang Y; Hickey AJ; Emmett L
Clin Nucl Med; 2016 Jul; 41(7):e327-39. PubMed ID: 26646995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
